Fierce Pharma
Fierce Biotech
Fierce Healthcare
Fierce Life Sciences Events
Advertise
About Us
Biotech
Cell & Gene Therapy
Clinical Data
Venture Capital
Deals
Research
Medtech
Devices
Diagnostics
AI and Machine Learning
CRO
Special Reports
Trending
Biologics
Clinical Development
Ophthalmology
Fierce 50
Special Report
Awards Gala
Awards
CRO Awards
Innovation Awards
Resources
Fierce Events
Industry Events
Webinars
Podcasts
Whitepapers
Survey
Events
Subscribe
Trending
Biotech
Cell & Gene Therapy
Clinical Data
Venture Capital
Deals
Research
Medtech
Devices
Diagnostics
AI and Machine Learning
CRO
Special Reports
Trending
Biologics
Clinical Development
Ophthalmology
Fierce 50
Special Report
Awards Gala
Awards
CRO Awards
Innovation Awards
Resources
Fierce Events
Industry Events
Webinars
Podcasts
Whitepapers
Survey
Events
Subscribe
Fierce Pharma
Fierce Biotech
Fierce Healthcare
Fierce Life Sciences Events
Advertise
About Us
debts
Fierce Pharma
Sarepta extends $700M debt to 2030 amid Elevidys uncertainty
The debt refinancing and private placement represent Sarepta's latest move in a series of intensive measures to improve its financial position.
Angus Liu
Aug 21, 2025 10:52am
Serina sheds AgeX assets to become debt-free
Jan 16, 2025 4:00am
Entero laying off staff, vacating office and pausing R&D
Aug 8, 2024 9:19am
Impel seeks loan leniency to avoid asset sale or bankruptcy
Aug 16, 2023 8:09am
Baxter brokers $4.25B sale of biopharma solutions segment
May 8, 2023 12:12am
Time may be running out for anti-aging biotech AgeX
Aug 15, 2022 11:20am
